Salicylic acid

Description

The provided information does not specify the chemical name, physical characteristics, or inactive ingredients of the drug. Therefore, a detailed description cannot be constructed based on the available data. Further information is required to create a comprehensive description.

Uses and Indications

This drug is indicated for the removal of genital warts, plantar warts, common warts, and flat warts. Common warts are characterized by their rough, "cauliflower-like" surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting tenderness and disrupting the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The product is intended for external use only. Healthcare professionals should ensure that the medication is applied exclusively to the affected area of the skin. Prior to application, the area should be cleaned and dried thoroughly.

The recommended dosage and frequency of administration will depend on the specific condition being treated. It is essential to follow the prescribed dosing regimen, which may vary based on individual patient needs and response to therapy.

Patients should be advised to apply the medication as directed, avoiding contact with eyes, mucous membranes, and open wounds. In the event of accidental contact, the area should be rinsed thoroughly with water.

Healthcare professionals should monitor patients for any adverse reactions and adjust the treatment plan as necessary.

Contraindications

Use of this product is contraindicated in the following situations:

Pregnancy and breastfeeding, as it may be harmful to the fetus or nursing infant.

Additionally, discontinue use and consult a healthcare professional if any of the following occur: chest pain, rapid heartbeat, faintness, dizziness, sudden unexplained weight gain, swelling of hands or feet, scalp irritation or redness, unwanted facial hair growth, or lack of hair regrowth after four months of use.

This product should not be applied to broken or irritated scalp.

Keep out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

For external use only, this product must be handled with care to ensure safety. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following symptoms occur: chest pain, rapid heartbeat, faintness, or dizziness. Additionally, patients should be instructed to stop use if they experience sudden, unexplained weight gain, swelling of the hands or feet, scalp irritation or redness, unwanted facial hair growth, or if there is no observable hair regrowth after four months of use.

This product may pose risks if used during pregnancy or while breastfeeding; therefore, it is crucial to counsel patients on the potential harm associated with its use in these populations.

To ensure safety, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Patients should also be advised to discontinue use if the scalp is broken or irritated, as this may exacerbate adverse effects. Regular monitoring of scalp condition and patient symptoms is recommended to ensure safe and effective use of the product.

Side Effects

Patients should be aware that the product is for external use only and must be kept away from fire and flame to prevent serious hazards. In the event of broken or irritated scalp, it is advised to discontinue use immediately to avoid exacerbating the condition.

These precautions are essential to ensure the safety and well-being of individuals using the product.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Natural Herbal Ingredients. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should be advised that the use of this medication may be harmful. There is a potential risk associated with the use of this drug during pregnancy, and it is important for healthcare providers to weigh the benefits against the risks when considering treatment options for women of childbearing potential. Caution is recommended, and alternative therapies should be considered to ensure the safety of both the mother and the fetus.

Lactation

Lactating mothers should be aware that the use of this medication may be harmful during breastfeeding. There is insufficient data regarding the excretion of this drug in human breast milk and its effects on breastfed infants. Therefore, caution is advised when considering the use of this medication in lactating individuals. It is recommended that healthcare professionals evaluate the potential risks and benefits before prescribing this medication to nursing mothers.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to keep the product out of reach of children. Should ingestion occur, immediate medical assistance is required. Healthcare professionals should advise caregivers to contact a Poison Control Center without delay.

Prompt intervention is crucial in managing potential overdosage scenarios to mitigate risks and ensure patient safety.

Nonclinical Toxicology

May be harmful if used during pregnancy or while breastfeeding. No non-teratogenic effects have been specified. There are no additional details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Patients should be informed to stop using the medication and consult a doctor if they experience chest pain, rapid heartbeat, faintness, or dizziness. Additionally, they should discontinue use and seek medical advice if they notice sudden, unexplained weight gain, swelling in the hands or feet, scalp irritation or redness, or unwanted facial hair growth. It is important to inform patients that if they do not observe hair regrowth within four months, they should also consult a doctor.

Healthcare providers should caution patients that the medication may be harmful if used during pregnancy or while breastfeeding. They should also emphasize that the medication should not be applied to broken or irritated scalp areas.

When using the medication, patients should wash the affected area thoroughly. They may soak the wart in warm water for five minutes and ensure the area is dried completely. Using an applicator, such as a cotton swab, patients should apply a layer of ointment to sufficiently cover each wart. It is important to allow the ointment to fully absorb and to cover the area with a bandage as needed. Patients should be instructed to repeat this procedure once or twice daily as necessary until the wart is removed, for a maximum duration of 12 weeks.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and protected from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the treatment is extracorporeal, with the procedure recommended to be repeated once or twice daily as needed until the wart is removed, for a duration of up to 12 weeks.

Clinicians should counsel patients to discontinue use and seek medical advice if they experience chest pain, rapid heartbeat, faintness, dizziness, sudden unexplained weight gain, swelling of hands or feet, scalp irritation or redness, unwanted facial hair growth, or if there is no observable hair regrowth after four months. Additionally, it is important to inform patients that the product may be harmful if used during pregnancy or while breastfeeding, and to keep it out of reach of children. In case of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Natural Herbal Ingredients, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)